Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-01

FDA Approved: PIQRAY — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for PIQRAY (alpelisib) from Novartis Pharmaceuticals Corporation. This action approves the requested supplemental ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Piqray (alpelisib)

Snippet

SUPPL AP for PIQRAY (ALPELISIB)